Sat.Nov 20, 2021 - Fri.Nov 26, 2021

article thumbnail

Epic's sepsis algorithm may have caused alert fatigue with 43% alert increase during pandemic

Fierce Healthcare

Epic's sepsis algorithm may have caused alert fatigue with 43% alert increase during pandemic. rtorrence. Tue, 11/23/2021 - 12:45.

141
141
article thumbnail

New COVID variant ‘may sidestep vaccine protection’

pharmaphorum

A new variant of COVID-19 identified in Botswana with dozens of mutations is being watched closely, amid fears it could be resistant to the effect of currently-used vaccines. The B.1.1.529 variant has more mutations affecting the spike protein targeted by vaccines than any other strain identified to date, although it’s not yet clear if it is more or less transmissible.

Vaccines 115
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Mix-and-match COVID-19 vaccines: New trial to add to growing body of research

Outsourcing Pharma

A new clinical trial of heterologous â or âmix-and-matchâ â combinations of COVID-19 vaccines is set to start in Pakistan: seeking to add to research on the effectiveness of such combinations.

Vaccines 110
article thumbnail

What Is PCD Pharma Franchise Monopoly Basis?

Fossil Remedies

Monopoly PCD Pharma franchise model is a specialized business model where the company provides franchises on a monopoly basis all over the country for marketing and distribution of products. Why does this business model hold a unique place in the business space? In fact, it is the most prevalent model. The reason is it I profitable and appealing. All leading and successful companies give it precedence.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Federal jury holds pharmacy chains CVS, Walgreens and Walmart responsible for role in opioid crisis

Fierce Healthcare

Federal jury holds pharmacy chains CVS, Walgreens and Walmart responsible for role in opioid crisis. hlandi. Tue, 11/23/2021 - 17:09.

127
127
article thumbnail

UK-wide whole genome sequencing for newborns is feasible – but there are some key questions to answer first

pharmaphorum

Genomics England, the Department of Health and Social Care’s genome-sequencing hub, has this year announced that support for whole genome sequencing (WGS) has reached a level at which its national rollout on the NHS may someday become a reality. The timing of this announcement is particularly opportune, as increasing knowledge and advances in WGS amongst scientists has resulted in the technology becoming increasingly affordable and effective, making its incorporation into the existing standardis

Hospitals 115

More Trending

article thumbnail

Pharmaceuticals and the environment: how can the industry put its best foot forward?

Pharma Mirror

In recent years, it has become more and more important to both consumers and investors that they support organisations which display a high level of social and environmental responsibility. This means that it’s no longer enough for businesses to manage their bottom lines and maintain profitability, they must also be conscious of the impact they have on the world around them.

article thumbnail

Major insurers won't pay for Biogen's Alzheimer’s drug until they get more proof that it works: Bloomberg survey

Fierce Healthcare

Major insurers won't pay for Biogen's Alzheimer’s drug until they get more proof that it works: Bloomberg survey. rking. Mon, 11/22/2021 - 16:43.

Insurance 117
article thumbnail

Time for change: PhRMA survey shows insurance creates barriers to healthcare in US

pharmaphorum

Health insurance is not enough to provide the necessary affordable access to care for the US’ most vulnerable, finds new PhRMA report. For too many Americans, insurance coverage is not providing the health security it’s meant to. The Pharmaceutical Research and Manufacturers of America’s (PhRMA) first Patient Experience Survey (PES) has found that three in ten people with medical insurance still face financial barriers to accessing healthcare and prescription medicines.

Insurance 115
article thumbnail

LMC Manna, IACT Health join in integrated research network

Outsourcing Pharma

The alliance is aimed at expanding service to pharmaceutical firms and other partners, and advancing treatment options for patients across North America.

98
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Telstar launches Usifroid global service platform for retrofitting & maintenance of freeze-dryers

Pharma Mirror

Terrassa (Barcelona) Telstar launches a new global service platform for retrofitting and maintenance of existing freeze-dryers, regardless of brand and model. Under Usifroid brand, this platform is specialized in providing a retrofitting and modernization service together with maintenance services and technical support to freeze-drying equipment for pharmaceutical production and research.

FDA 52
article thumbnail

HHS warns of increasing zero-day attacks in healthcare

Fierce Healthcare

HHS warns of increasing zero-day attacks in healthcare. rtorrence. Wed, 11/24/2021 - 11:05.

145
145
article thumbnail

Re-envisioning mental health treatment using clinical VR

pharmaphorum

Skip Rizzo, PhD, research director for medical virtual reality at the University of Southern California’s Institute for Creative Technologies (USC ICT), tells us how its virtual reality (VR) therapy BRAVEMIND is changing PTSD treatment and how pharma can leverage clinical VR. “There’s a strong evidence base for VR applications in many areas, but it’s also breaking down barriers to care.

article thumbnail

Reify Health launches tool to gauge clinical trial diversity

Outsourcing Pharma

The StudyTeam Diversity Reporting feature is intended to aid sites and sponsors measure their efforts to reach patients from underrepresented communities.

88
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Saluting the Winners of the 2021 ACE Awards

Pharma Marketing Network

“The Healthcare Businesswomen’s (HBA) Advancement. Commitment. Engagement. (ACE) Awards recognize companies committed to ensuring that gender diversity and leadership opportunities for women are part of their organizational DNA.”. The HBA’s 2021 ACE Awards opened saluting ACE winner honorees over the last decade and a half, recognizing those companies who have driven impact and results, from Johnson and Johnson to Bayer.

52
article thumbnail

Patients with do-not-resuscitate orders have worse outcomes, higher death rates, study finds

Fierce Healthcare

Patients with do-not-resuscitate orders have worse outcomes, higher death rates, study finds. agliadkovskaya. Wed, 11/24/2021 - 13:09.

120
120
article thumbnail

AstraZeneca cuts the ribbon on its $1bn R&D lab in Cambridge

pharmaphorum

After years of delays and rising costs, AstraZeneca has formally unveiled its $1 billion R&D facility in Cambridge, said to be the biggest science lab of its kind in the UK. The Discovery Centre (DISC) based in the Cambridge Biomedical Campus – first given the green light in 2015 – is being officially opened today by Prince Charles. It can accommodate more than 2,200 research scientists, has 19,000 square metres of lab space, and boasts “the most advanced robotics, high-throughput scre

Hospitals 105
article thumbnail

Patient-centric eClinical tech can boost trials: Jeeva Informatics

Outsourcing Pharma

Leaders from the trial tech provider discuss how human-focused technology on eClinical platforms can tackle inefficiencies associated with traditional studies.

59
article thumbnail

AI in Pharma and Biotech Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2030

Pharma Mirror

AI in Pharma and Biotech Market: Introduction Artificial Intelligence (AI) in pharma refers to the system of interconnected and automated technologies in the biotech industry that can function autonomously, with little or no human intervention. AI is an emerging technology that is being applied in numerous facets of the pharma sector, ranging from drug development to diagnosis and even patient care.

article thumbnail

Two private equity firms near $17B deal to acquire Athenahealth: WSJ report

Fierce Healthcare

Two private equity firms near $17B deal to acquire Athenahealth: WSJ report. hlandi. Sun, 11/21/2021 - 21:34.

130
130
article thumbnail

FDA clears Takeda drug for post-transplant CMV infections

pharmaphorum

Takeda has scored the first-ever FDA approval of a treatment for refractory cytomegalovirus (CMV) infections in organ transplant patients, which can lead to an increased risk of complications and even death. Livtencity (maribavir) has been cleared for use in transplant patients aged 12 or over with CMV infections that do not respond to first-line treatment with current antiviral drugs for CMV, such as ganciclovir, valganciclovir, foscarnet and cidofovir.

FDA 105
article thumbnail

Druggist - Untitled Article

Druggist

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, The post appeared first on Druggist.Online.

52
article thumbnail

Pharmacist : An intergral part of health care

Pharma Tutor

Pharmacist : An intergral part of health care. About Author. Dr. R. S. Thakur. Chief Editor, Journal of Pharmaceutical Research. Krupanidhi College of Pharmacy, Bengaluru-560035. Email: drramsthakur@gmail.com. . admin. Sat, 11/20/2021 - 16:19. Tags. Articles.

52
article thumbnail

Amid Talkspace leadership exodus and stock freefall, law firms investigating potential claims of securities violations

Fierce Healthcare

Amid Talkspace leadership exodus and stock freefall, law firms investigating potential claims of securities violations. hlandi. Wed, 11/24/2021 - 11:09.

109
109
article thumbnail

Chinese tech giant Baidu licenses mRNA algorithm to Sanofi

pharmaphorum

Sanofi has bolstered its push into mRNA-based therapies with a new licensing deal – but not as might be expected with some up-and-coming biotech company. The French drugmaker has been enticed by an artificial intelligence (AI) algorithm developed by Chinese tech giant Baidu, which controls most of China’s search engine traffic and is sometimes referred to as the country’s Google.

Vaccines 105
article thumbnail

Druggist - Untitled Article

Druggist

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged.

52
article thumbnail

University of Glasgow reveals drug design for new Alzheimer’s treatments

Pharma Times

A team of scientists and pharmaceutical collaborators have discovered a ‘bench to bedside’ drug design, which will hopefully improve the future treatment of Alzheimer’s disease.

61
article thumbnail

Industry Voices—Health plans look to HIEs while expanding population health work

Fierce Healthcare

Industry Voices—Health plans look to HIEs while expanding population health work. hlandi. Mon, 11/22/2021 - 20:23.

125
125
article thumbnail

Reshaping events in pharma

pharmaphorum

Healthcare professional (HCP) engagement experienced significant shifts during the acute phase of the pandemic, as COVID-19 forced a rethink of traditional pharmaceutical sales and marketing practices, including the digitisation of events. With medical conferences and events long a mainstay for pharma-HCP interactions, the pandemic’s travel restrictions, and lockdowns forced these in-person meet-ups to go virtual.

article thumbnail

AstraZeneca opens new advanced therapeutics R&D facility in Cambridge

Outsourcing Pharma

AstraZeneca has built a new R&D facility - The Discovery Centre (DISC) - in Cambridge in the UK.

65
article thumbnail

EC grant Trodelvy marketing authorisation for treatment of breast cancer

Pharma Times

With the latest approval from the EC, patients in Europe suffering from metastatic triple-negative breast cancer can now receive Gilead Science’s Trodlevy as part of their treatment.

49
article thumbnail

Survey: Majority of Medicaid managed care plans offered health equity benefits in 2020

Fierce Healthcare

Survey: Majority of Medicaid managed care plans offered health equity benefits in 2020. rking. Mon, 11/22/2021 - 14:40.

122
122
article thumbnail

Turkey’s home-grown COVID vaccine project nears fruition

pharmaphorum

Turkey could have its own COVID-19 vaccine Turkovac available for use by the end of the year, according to the country’s Health Minister Fahrettin Koca. An emergency use authorisation (EUA) application for the inactivated SARS-CoV-2 vaccine has been submitted to the Turkish Medicines and Medical Devices Agency (TITCK) on the back of preliminary data from ongoing phase 3 trials.

article thumbnail

What is Lorem Ipsum?

Druggist

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged.

40